Science Explorer Interactive view Map
Company · Hamburg · Germany

Evotec (Germany)

World rank, all time
#17,082
of 42,892
Rank in Germany
#838
of 2,077
Research works
187
▲ 12% vs 2013–17
Citations
5.3k
28.3 per fractional work
Top-10% rate
12.4%
record average 16.5%
Open access
44%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.10× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.13× its world share, 16 worksBiochemistry, Geneti…Immunology and Microbiology: 5.57× its world share, 3 worksImmunology and Micro…Neuroscience: 2.14× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.43× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.28× its world share, 1 worksChemistryComputer Science: 0.16× its world share, 1 worksComputer ScienceEngineering: 0.09× its world share, 1 worksEngineeringEnvironmental Science: 0.23× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.20× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.09× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.05× its world share, 0 worksHealth ProfessionsMedicine: 2.58× its world share, 25 worksMedicineNursing: 0.23× its world share, 0 worksNursingArts and Humanities: 0.02× its world share, 0 worksArts and HumanitiesDecision Sciences: 0.01× its world share, 0 worksDecision SciencesSocial Sciences: 0.05× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.1×. Every wedge is a field page.

Which keywords describe research at Evotec (Germany)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glomerular Diseases, Nephrotic Syndrome, Cardiovascular Disease, Cancer, Immunotherapy, Fibrosis, Inflammation and Biomarkers.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation4▲ 4.2×20 topics
  2. Cancer4▲ 6.2×14 topics
  3. Cardiovascular Disease4▲ 7.2×9 topics
  4. Glomerular Diseases4▲ 248×1 topic
  5. Nephrotic Syndrome4▲ 248×1 topic
  6. Immunotherapy4▲ 10×6 topics
  7. Fibrosis3▲ 36×4 topics
  8. Biomarkers3▲ 8.5×6 topics
  9. Chronic Kidney Disease3▲ 23×3 topics
  10. Cancer Immunotherapy3▲ 34×3 topics
  11. Oxidative Stress2▲ 3.1×13 topics
  12. Diabetic Nephropathy2▲ 68×1 topic
  13. Global Burden2▲ 8.3×2 topics
  14. Glomerular Filtration Rate2▲ 110×1 topic
  15. TGF-ß2▲ 29×2 topics
  16. Treatment2▲ 3.7×8 topics
  17. Gene Expression2▲ 7.0×6 topics
  18. Biogenesis2▲ 22×3 topics
  19. Pluripotent Stem Cells2▲ 73×2 topics
  20. Immunity2▲ 8.8×4 topics
  21. Metabolic Syndrome2▲ 4.6×6 topics
  22. Tumor Regression2▲ 33×2 topics
  23. Clinical Guidelines2▲ 12×3 topics
  24. Mitochondrial Dysfunction2▲ 11×4 topics
  25. Transcriptional Regulation2▲ 21×4 topics
  26. Data Integration2▲ 18×2 topics
  27. Exosomes2▲ 49×1 topic
  28. Extracellular Vesicles2▲ 49×1 topic
  29. Prognostic Factors2▲ 6.8×2 topics
  30. Genetic Mutations1▲ 6.6×2 topics
  31. Molecular Characterization1▲ 16×2 topics
  32. RNA-Seq1▲ 27×2 topics
  33. CAR T Cells1▲ 36×1 topic
  34. Chimeric Antigen Receptor1▲ 36×1 topic
  35. Single-Cell1▲ 60×1 topic
  36. Transcriptomics1▲ 60×1 topic
  37. Glycosylation1▲ 22×3 topics
  38. Calcium Signaling1▲ 31×2 topics
  39. Macrophages1▲ 13×4 topics
  40. Monoclonal Antibodies1▲ 25×2 topics

Which research topics does Evotec (Germany) publish most on?

By volume in 2022–2025: Renal Diseases and Glomerulopathies, Chronic Kidney Disease and Diabetes, Extracellular vesicles in disease and CAR-T cell therapy research.

  1. 1 Renal Diseases and Glomerulopathies Nephrology 4 works
  2. 2 Chronic Kidney Disease and Diabetes Nephrology 2 works
  3. 3 Extracellular vesicles in disease Molecular Biology 2 works
  4. 4 CAR-T cell therapy research Oncology 1 works
  5. 5 Single-cell and spatial transcriptomics Molecular Biology 1 works
  6. 6 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 1 works
  7. 7 Renal and related cancers Molecular Biology 1 works
  8. 8 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 1 works
  9. 9 Birth, Development, and Health Pediatrics, Perinatology and Child Health 1 works
  10. 10 Pluripotent Stem Cells Research Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.5%not open55.5%

World: 28% of research is openly available.

with international co-authors49.5%domestic only50.5%

World: 19% is written across borders.

How has Evotec (Germany)'s research output changed?

Output in 2018–2022 was 12% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Hamburg

All research institutions in Hamburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.